Home

Conmoción Avanzar Artístico novartis ceo vas narasimhan Marchito monitor Listo

Novartis 2019: habla el CEO | PharmaBiz.NET
Novartis 2019: habla el CEO | PharmaBiz.NET

Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Novartis CEO Vas Narasimhan urges global push for free and open movement of  trade and talent - The Hindu BusinessLine
Novartis CEO Vas Narasimhan urges global push for free and open movement of trade and talent - The Hindu BusinessLine

Basel is very open to newcomers - Basel Area Business & Innovation
Basel is very open to newcomers - Basel Area Business & Innovation

Novartis CEO sees 'better place' with Covid by year-end | Mint
Novartis CEO sees 'better place' with Covid by year-end | Mint

El CEO Vasant Narasimhan del fabricante suizo de drogas Novartis hace un  discurso durante la ceremonia de apertura de la nueva fábrica de terapia  celular y génica de la compañía en Stein,
El CEO Vasant Narasimhan del fabricante suizo de drogas Novartis hace un discurso durante la ceremonia de apertura de la nueva fábrica de terapia celular y génica de la compañía en Stein,

There's an explosion of data & digital opportunities in Indian healthcare: Vasant  Narasimhan, CEO, Novartis - The Economic Times
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times

Novartis CEO Vas Narasimhan on Culture, Strategy and Change
Novartis CEO Vas Narasimhan on Culture, Strategy and Change

Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis's Vas Narasimhan on AI, Data Science for Company Operations

Novartis CEO Steers Drug Maker Back to R&D - WSJ
Novartis CEO Steers Drug Maker Back to R&D - WSJ

Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT

Novartis continúa la transformación en una empresa líder de medicamentos
Novartis continúa la transformación en una empresa líder de medicamentos

El director ejecutivo, Vas Narasimhan, del fabricante suizo de drogas  Novartis, se dirige a la conferencia de prensa anual de la compañía en  Basilea, Suiza, el 30 de enero de 2019. REUTERS/Arnd
El director ejecutivo, Vas Narasimhan, del fabricante suizo de drogas Novartis, se dirige a la conferencia de prensa anual de la compañía en Basilea, Suiza, el 30 de enero de 2019. REUTERS/Arnd

Un médico para Novartis | Economía | EL PAÍS
Un médico para Novartis | Economía | EL PAÍS

Novartis prevé destinar más de 8.800 millones a la compra de otras empresas  en 2019 | PlantaDoce
Novartis prevé destinar más de 8.800 millones a la compra de otras empresas en 2019 | PlantaDoce

Una vacuna no bastará para combatir el covid, dice jefe de Novartis
Una vacuna no bastará para combatir el covid, dice jefe de Novartis

Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT

CEO of Novartis pinning hopes on malaria drug - Basel Area Business &  Innovation
CEO of Novartis pinning hopes on malaria drug - Basel Area Business & Innovation

Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager  magazin
Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager magazin

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company -  YouTube
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube

تويتر \ Novartis على تويتر: "Today we announce Vas Narasimhan as new Novartis  CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements  https://t.co/2VauFSX2Be https://t.co/80YIKxip4I"
تويتر \ Novartis على تويتر: "Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I"

Embassy of India, Berne, Switzerland : Events/Photo Gallery
Embassy of India, Berne, Switzerland : Events/Photo Gallery

Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on  sales | Fierce Pharma
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma

Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Vas Narasimhan: the American trying to reshape Novartis | Financial Times

The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED

Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash  | Barron's
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's

Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT |  Fierce Pharma
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma